Diabetes Drug Development and Endocrinology
Revealing new possibilities in diabetes and endocrinology drug development.
Our unique perspective shapes possibilities in diabetes clinical research.
At Covance, our endocrinology professionals leverage their extensive diabetes and lipid disorder experience to help you create streamlined solutions. Whether you are a small biotech or a large-sized pharmaceutical company, we work relentlessly to enable you to achieve specific development milestones.
Finding the cure—faster.
As the prevalence of diabetes continues to grow, the race to find a cure is intensifying. Our therapeutically-focused experts can help you accelerate the process with proven strategies designed to help you reach your development milestones sooner. Let us help you cross the finish line first.
Reach smarter clinical decisions faster with preclinical mechanism-of-action studies
Quantify insulin secretion with customized glucose clamps in healthy normal volunteers and / or patients with Type 1 or Type 2 diabetes
Speed timelines by integrating preclinical safety assessments with proof-of-concept studies
Leverage our experience and operational capabilities in global cardiovascular outcome mega-trials with endpoint adjudication
Start the right trials, pre-IND, and accelerate your market approval by incorporating Market Access and regulatory strategies into early phase designs
In endocrine studies, including diabetes, results depend on comprehensive testing solutions – from the lab to the clinic. We help you achieve success by ensuring fully standardized methodology across all of our five global NGSP Level 1 certified central laboratories, to provide you with exceptionally accurate worldwide data for A1C testing. Couple our testing leadership with our proprietary Xcellerate® knowledgebase that helps you optimize site selection and recruitment, and you’ll have a diabetes program that works harder for you.
Revealing new opportunities to grow your business.
Like you, we are passionate about science. From exploring novel uses for Type 2 diabetes drugs in treating Type 1 disease to proactively addressing potential opportunities for biologics, biosimilars, devices and novel insulin delivery systems, we stay on the cutting edge of diabetes and endocrinology drug development. Our goal is to deliver Solutions Made Real® that set you up for success.
End-to-end solutions to extend your team.
We deliver a holistic suite of diabetes and endocrinology drug development solutions. From lead optimization through commercialization, we are personally invested in maximizing the ROI of your development program.